Neo Ivy Capital Management Acquires New Holdings in Zimmer Biomet Holdings, Inc.
| RDGL Stock | USD 0.07 0 3.28% |
About 60% of Vivos' investor base is looking to short. The analysis of current outlook of investing in Vivos Inc suggests that many traders are alarmed regarding Vivos' prospects. Vivos' investing sentiment shows overall attitude of investors towards Vivos Inc.
Vivos otc stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Vivos daily returns and investor perception about the current price of Vivos Inc as well as its diversification or hedging effects on your existing portfolios.
Vivos |
Neo Ivy Capital Management bought a new position in Zimmer Biomet Holdings, Inc. in the third quarter, Holdings Channel.com reports. The institutional investor bought 1,384 shares of the medical equipment providers stock, valued at approximately 150,000. Other hedge funds have also modified their holdings of the company. Brown Financial Advisors raised
Read at thelincolnianonline.com
 |
Vivos Fundamental Analysis
We analyze Vivos' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vivos using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vivos based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Asset
Net Asset Comparative Analysis
Vivos is currently under evaluation in net asset category among its peers. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Vivos Inc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Vivos otc stock to make a market-neutral strategy. Peer analysis of Vivos could also be used in its relative valuation, which is a method of valuing Vivos by comparing valuation metrics with similar companies.
Peers
Vivos Related Equities
| SEMHF | Siemens Healthineers | 0.30 |
| ||
| PHG | Koninklijke Philips | 1.20 |
| ||
| ABT | Abbott Laboratories | 1.20 |
| ||
| MDT | Medtronic PLC | 1.65 |
| ||
| EW | Edwards Lifesciences | 1.77 |
| ||
| ZBH | Zimmer Biomet | 2.04 |
| ||
| BSX | Boston Scientific | 2.65 |
| ||
| SYK | Stryker | 3.14 |
| ||
| DXCM | DexCom | 3.26 |
|
Other Information on Investing in Vivos OTC Stock
Vivos financial ratios help investors to determine whether Vivos OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Vivos with respect to the benefits of owning Vivos security.